Authors
Latest:
Fixed-Duration Ibrutinib Plus Venetoclax Shows Long-Term Efficacy in First-Line CLL/SLL TreatmentIbrutinib plus venetoclax shows promising long-term survival rates, including those who are considered high risk.
Latest:
John Green: "Tuberculosis Anywhere Is a Threat to People Everywhere"Tuberculosis is a long-standing global health issue that requires continued public health vigilance to prevent a resurgence of this preventable and curable disease.
Latest:
Pharmacy-Led Enhanced Patient Education in the Emergency DepartmentIn this retrospective study, investigators evaluated a pharmacy-led initiative in the emergency department (ED), finding a potential reduction in ED revisits and hospital readmissions, though results were not statistically significant.
Latest:
Streamlining Pain Management: Shore Medical Center's Pharmacist-Driven Opioid Conversion InitiativeShore Medical Center enhances patient safety with a pharmacy-driven intravenous to oral opioid conversion protocol, minimizing risks and improving pain management.
Latest:
TXNIP inhibitors: A New Class of Agents for Diabetes TreatmentTXNIP inhibition could prevent beta cell loss and protect beta cell function to potentially contribute to diabetes management and its complications.
Latest:
A Review of Treatment Options, Guidelines for Heart Failure With Preserved Ejection FractionWith the release of the 2022 AHA/ACC Guidelines for the Management of Heart Failure, patients with HFpEF now have a wider range of treatment options.
Latest:
PQA-Supported Research Examines Cost Barriers to Medication Access and AdherenceThe Pharmacy Quality Alliance developed the “Medication Access Framework for Quality Measurement” to address the social determinants of health that hinder patient medication access and contribute to poor health outcomes.
Latest:
Pharmacy’s Role in Public Health InitiativesPanelists share final thoughts and advice regarding the critical role pharmacy has played and continues to play in public health initiatives.
Latest:
AAN 2025: GLP-1 Analogues' Promise in Alzheimer Disease TreatmentGlucagon-like peptide-1 (GLP-1) analogs demonstrate potential to address multiple pathological processes in Alzheimer disease, with promising early research suggesting cognitive improvements and potential for future treatment.
Latest:
Updates on 2022 Changes to the American Diabetes Association Standards of CareMetformin has been the drug of choice for the treatment of diabetes since the 1950s, but new changes suggest the consideration of SGLT-2 inhibitors or GLT-1 agonists.
Latest:
The Evolving Role of Adjuvant Immunotherapy in Resected Renal Cell Carcinoma: Key Findings and Future DirectionsThe adjuvant therapy has demonstrated varied efficacy for patients.
Latest:
Risks Facing Pharmacists, and Their Associated Costs, Are IncreasingThe cost of defending license matters and malpractice claim costs have increased over a 5-year period (2017-2022).
Latest:
Paradoxical Hypotension After Inadvertent Intravenous Administration of EpinephrineRaising awareness of the potentially fatal cardiovascular complications of epinephrine toxicity.
Latest:
Pharmacists Play Essential Role in Addressing Health Care DisparitiesDiversity, equity, and inclusion programs in pharmacy can lead to better health outcomes for patients.
Latest:
Elevating Stroke Care: A Pharmacy Perspective on Telestroke ServicesIn recent years, telestroke services have transformed stroke care delivery, especially in rural or underserved areas.
Latest:
An Overview of Vitamins and Supplements in Multiple SclerosisBy examining the evidence, pharmacists can gain insights into whether these supplements could be integrated into MS treatment regimens to improve patient outcomes.
Latest:
A Training Program Addresses Challenges in USP <797> Personnel Competency Evaluations at a Multisite InstitutionImplementing these standards can be logistically challenging.
Latest:
Asembia AXS25: Pharmacy Perspectives on the Inflation Reduction ActExperts share operational challenges and patient care implications of the Inflation Reduction Act's (IRA) drug pricing reforms.
Latest:
Revolutionizing Outpatient Oncology Care: The Seamless Integration of Artificial IntelligenceArtificial intelligence holds immense potential to address the rising demand for oncology services and improve patient outcomes by facilitating more effective, efficient, personalized cancer care.
Latest:
Consumers Are Leading the Change in the Health Care RevolutionThey can continue to put pressure on companies and regulatory bodies to make the system work for them and not the other way around.
Latest:
The Consequences of Discontinuing CGRP Inhibitors in Migraine PatientsPharmacists must understand the value of monitoring changes in quality of life and headache frequency to help facilitate the decision to continue, discontinue, or restart migraine prophylaxis.
Latest:
Clinical Insight: The Use of GLP-1 Agonist Medications for Weight LossAn increase in the use of GLP-1 agonists for weight loss is affecting patients with diabetes who rely on these medications.
Latest:
Pharmacy Technicians Are Valued More Than Ever: Insights Into a Team-Centered Immunization ApproachWith many people remaining to be vaccinated against COVID-19 and everyone 6 months and older needing an annual influenza vaccine for the 2021-2022 season, many pharmacies are turning to pharmacy technicians to assist in the process.
Latest:
Combating the Post-Pandemic Pharmacy Workforce ShortageThe pharmaceutical industry is facing a critical talent shortage caused by fewer students entering the field, burnout and a lack of stability. We offer ways to combat the shortage.
Latest:
The Evolution of Precision Medicine in PharmacyPrecision medicine in pharmacy has the potential to revolutionize patient care by optimizing drug selection, dosing, and monitoring.
Latest:
Conversations About SDOH Are Difficult but VitalInitiating such discussions can be hard, but they can greatly affect health outcomes.
Latest:
Understanding the Implications of the FDA’s New Boxed Warning for CAR T-Cell TherapyIn November 2023, the FDA announced an investigation of CAR T-cell therapy based on several reported secondary T-cell malignancies.
